Elif Ayça Şahin | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Elif Ayça Şahin
Gazi University Faculty of Medicine, Turkey

Elif Ayça Şahin
Affiliation Gazi University Faculty of Medicine
Country Turkey
Scopus ID 57548691200
Documents 28
Citations 44
h-index 4
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0002-2215-2756

The Innovative Research Award recognizes researchers whose scholarly activities contribute to the advancement of scientific knowledge through original investigations, peer-reviewed publications, and measurable research impact. Elif Ayça Şahin of Gazi University Faculty of Medicine has established a documented record of scientific contributions within medicine and health sciences, particularly through studies addressing infectious diseases, microbiology, molecular biology, respiratory health, and translational biomedical research. Her publication portfolio demonstrates engagement with contemporary healthcare challenges and emerging diagnostic methodologies.[1]

Abstract

This academic recognition article presents a scholarly overview of Elif Ayça Şahin’s research activities, publication record, and scientific contributions in medicine and health sciences. The profile highlights peer-reviewed publications focused on infectious diseases, fungal diagnostics, respiratory viral epidemiology, molecular mechanisms of disease, and translational biomedical investigations. Through a combination of laboratory-based and clinically relevant studies, the researcher has contributed to expanding knowledge in diagnostic microbiology, public health surveillance, and molecular medicine. The documented publication portfolio and citation metrics support consideration for the Innovative Research Award within the International Forensic Scientist Awards framework.[1]

Keywords

Medicine, Health Sciences, Infectious Diseases, Molecular Biology, Clinical Microbiology, Respiratory Viruses, Fungal Diagnostics, Translational Research, Biomedical Science, Scientific Publications.

Introduction

Modern biomedical research increasingly relies on interdisciplinary approaches that connect laboratory investigations with clinical applications. Researchers operating within this environment contribute to improved diagnostic accuracy, disease monitoring, therapeutic development, and evidence-based healthcare decision-making. Elif Ayça Şahin’s body of work reflects participation in this evolving scientific landscape through investigations addressing infectious pathogens, molecular pathways, fungal diseases, and epidemiological trends affecting patient care.[2]

Research Profile

Elif Ayça Şahin is affiliated with Gazi University Faculty of Medicine, Turkey. According to Scopus-indexed records, the researcher has authored 28 scholarly documents with 44 citations and an h-index of 4. The research portfolio spans medicine and health sciences with emphasis on infectious disease diagnostics, microbiology, immunological responses, respiratory viral infections, and molecular mechanisms associated with disease progression. The published literature demonstrates engagement with both experimental and clinically oriented investigations that contribute to the broader understanding of human health and disease.[1]

Research Contributions

  • Investigation of autophagy-related molecular pathways and microRNA regulation in experimental disease models.[2]
  • Development and evaluation of fungal screening methodologies for diagnostic applications in clinical microbiology.[3]
  • Comparative studies examining fungal survival characteristics across environmental surfaces relevant to infection control.[4]
  • Systematic review contributions addressing rare fungal infections and associated clinical outcomes.[5]
  • Retrospective analyses exploring respiratory virus prevalence, immune status, and co-detection patterns in healthcare settings.[6]

Publications

  1. Inhibition of miR-106a/b Modulates Autophagy-Related Gene Expression in the ULK1–Beclin-1–ATG12 Axis in Experimental Colitis. Bratislava Medical Journal (2026).
  2. Preliminary evaluation of a SYBR Green-based screening approach for selected fungal targets in simulated cerebrospinal fluid samples. Journal of Health Sciences and Medicine (2026).
  3. Candidozyma (Candida) auris’in Farklı Yüzeylerdeki Canlılık Süresi: Diğer Candida Türleriyle Karşılaştırmalı Bir In Vitro Çalışma. Flora the Journal of Infectious Diseases and Clinical Microbiology (2026).
  4. Meningitis caused by Candida dubliniensis in a patient with meningioma: a systematic review of the literature. Irish Journal of Medical Science (2026).
  5. Impact of immune status on respiratory virus prevalence and co-detection patterns: a retrospective analysis (2019–2024). BMC Pulmonary Medicine (2026).

Research Impact

The available publication and citation indicators demonstrate a developing research profile supported by peer-reviewed scientific output and measurable scholarly engagement. Research activities encompass both experimental investigations and clinically relevant analyses, facilitating knowledge generation in microbiology, infectious disease research, and molecular medicine. Citation activity and indexed publications indicate dissemination within the international scientific community and contribute to evidence-based healthcare research.[1]

Award Suitability

The Innovative Research Award recognizes individuals whose research demonstrates originality, scientific rigor, and meaningful contribution to their discipline. Based on the documented publication record, involvement in contemporary biomedical research topics, and contributions to infectious disease diagnostics and molecular investigations, Elif Ayça Şahin meets several scholarly characteristics associated with research excellence. The diversity of recent publications and continued engagement with emerging healthcare challenges support consideration for recognition within the International Forensic Scientist Awards program.[2][6]

Conclusion

Elif Ayça Şahin has contributed to medicine and health sciences through research addressing molecular biology, infectious diseases, fungal diagnostics, and respiratory health. The scholarly record reflects participation in peer-reviewed research, interdisciplinary collaboration, and the dissemination of scientific findings through recognized journals. These achievements collectively demonstrate a research profile aligned with the objectives of the Innovative Research Award and the broader mission of promoting scientific advancement and innovation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Elif Ayça Şahin, Author ID 57548691200. Scopus.
    https://www.scopus.com/pages/authors/57548691200
  2. Şahin EA, et al. (2026). Inhibition of miR-106a/b Modulates Autophagy-Related Gene Expression in the ULK1–Beclin-1–ATG12 Axis in Experimental Colitis. Bratislava Medical Journal.
    https://doi.org/10.1007/s44411-026-00796-8
  3. Şahin EA, et al. (2026). Preliminary evaluation of a SYBR Green-based screening approach for selected fungal targets in simulated cerebrospinal fluid samples. Journal of Health Sciences and Medicine.
    https://doi.org/10.32322/jhsm.1937982
  4. Şahin EA, et al. (2026). Candidozyma (Candida) auris’in Farklı Yüzeylerdeki Canlılık Süresi. Flora the Journal of Infectious Diseases and Clinical Microbiology.
    https://doi.org/10.5578/flora.2026021525
  5. Şahin EA, et al. (2026). Meningitis caused by Candida dubliniensis in a patient with meningioma. Irish Journal of Medical Science.
    https://doi.org/10.1007/s11845-026-04433-9
  6. Şahin EA, et al. (2026). Impact of immune status on respiratory virus prevalence and co-detection patterns: a retrospective analysis (2019–2024). BMC Pulmonary Medicine.
    https://doi.org/10.1186/s12890-026-04310-2

Peter Kiefner | Health Professions | Industry Impact Award

Published on by Forensic Scientist Awards

Industry Impact Award

Peter Kiefner
Praxis für Endodontologie und Dentale Traumatologie, Germany
Peter Kiefner
Affiliation Praxis für Endodontologie und Dentale Traumatologie
Country Germany
Scopus ID 40261698700
Documents 4
Citations 227
h-index 4
Subject Area Health Professions
Event International Forensic Scientist Awards

The Industry Impact Award recognition article highlights the scholarly profile and professional research contributions of Peter Kiefner, affiliated with the Praxis für Endodontologie und Dentale Traumatologie in Germany. His academic work is associated with evidence-based endodontics, dental traumatology, and advanced imaging applications in clinical dentistry. Bibliometric indicators indexed in Scopus demonstrate measurable scholarly influence through publications, citations, and interdisciplinary collaboration within health professions research.[1]

Abstract

Peter Kiefner has contributed to scholarly investigations within endodontics and dental traumatology, with particular emphasis on the use of cone-beam computed tomography (CBCT) and clinical decision-making in modern dental practice. His publications have supported evidence-based approaches to diagnostic imaging and treatment planning. Citation metrics indicate sustained academic engagement and recognition within relevant research communities.[1][2]

Keywords

Endodontics, Dental Traumatology, Cone-Beam Computed Tomography, CBCT, Clinical Dentistry, Diagnostic Imaging, Health Professions, Research Impact, Dental Research, Industry Impact Award

Introduction

Contemporary dental practice increasingly relies on advanced imaging technologies to improve diagnostic accuracy and patient outcomes. Cone-beam computed tomography has emerged as a valuable tool for evaluating complex endodontic conditions, supporting clinicians in treatment planning and risk assessment. Research contributions associated with Peter Kiefner have been linked to studies examining the practical use of CBCT among endodontic specialists and the broader integration of imaging technologies into clinical workflows.[2]

Research Profile

According to indexed bibliometric records, Peter Kiefner has authored and co-authored scholarly works within the Health Professions domain. His research activities demonstrate engagement with clinically relevant topics in endodontics, diagnostic imaging, and dental traumatology. Scopus records indicate four indexed publications, 227 citations, and an h-index of 4, reflecting measurable academic visibility and contribution to the scientific literature.[1]

Research Contributions

  • Contributed to clinical investigations involving cone-beam computed tomography applications in endodontics.
  • Supported evidence-based diagnostic methodologies in dental practice.
  • Participated in collaborative research involving endodontic specialists and academic institutions.
  • Contributed to publications addressing imaging-guided treatment planning and dental trauma management.

Publications

One of the notable publications associated with Peter Kiefner is the article titled “When and how do endodontic specialists use cone-beam computed tomography?”, published in the Australian Endodontic Journal in 2019. The study explored utilization patterns of CBCT among endodontic specialists and contributed valuable evidence regarding advanced imaging practices in clinical endodontics. The publication has received notable citation attention within the dental research community.[2]

Research Impact

Bibliometric indicators provide evidence of academic influence through citation activity and scholarly dissemination. With 227 citations recorded across indexed publications, Peter Kiefner’s work has contributed to professional discussions regarding dental imaging, endodontic diagnostics, and clinical practice standards. Such impact highlights the relevance of research-driven approaches within healthcare and dental sciences.[1]

Award Suitability

The Industry Impact Award recognizes individuals whose scholarly activities demonstrate practical significance and measurable influence within professional sectors. Peter Kiefner’s research profile aligns with these objectives through contributions to clinically applicable dental research, evidence-based diagnostic methodologies, and influential publications that support improved healthcare practices. The documented citation performance and relevance of his work indicate suitability for recognition within an international academic awards framework.[1][2]

Conclusion

Peter Kiefner’s scholarly profile reflects sustained engagement with research areas relevant to endodontics and dental traumatology. Through published research, citation impact, and contributions to clinical knowledge, his work has supported the advancement of evidence-based dental care. These achievements collectively underscore his relevance within the Health Professions research landscape and provide a foundation for recognition through the Industry Impact Award.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Peter Kiefner, Author ID 40261698700. Scopus.
    https://www.scopus.com/pages/authors/40261698700
  2. Krug, R., Connert, T., Beinicke, A., Kiefner, P., Weiger, R., & Krästl, G. (2019). When and how do endodontic specialists use cone-beam computed tomography? Australian Endodontic Journal.
    DOI: https://doi.org/10.1111/aej.12360
  3. International Forensic Scientist Awards. (n.d.). Award Information and Recognition Platform.
    forensicscientist.org

Akerke Chayakova | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Akerke Chayakova
Astana Medical University, Kazakhstan

Akerke Chayakova
Affiliation Astana Medical University
Country Kazakhstan
Scopus ID 57226888892
Documents 4
Citations 6
h-index 2
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0002-8398-3684

Akerke Chayakova is affiliated with Astana Medical University and has contributed to research in medicine, emergency healthcare systems, public health analytics, and the application of digital technologies in healthcare. Her scholarly activities focus on emergency medical services, epidemiological assessment, geospatial health analysis, and healthcare decision-making processes. Through peer-reviewed publications and interdisciplinary investigations, her work contributes to evidence-based healthcare planning and the understanding of population-level health dynamics.[1]

Abstract

This article summarizes the research profile and academic contributions of Akerke Chayakova. Her research addresses emergency medical service performance, urban health environments, healthcare analytics, pandemic response assessment, and artificial intelligence applications in medicine. Through quantitative investigations and population-based studies, her work supports improvements in healthcare management, emergency response planning, and clinical decision support systems.[2]

Keywords

Emergency Medical Services, Public Health, Healthcare Analytics, Artificial Intelligence, Epidemiology, Geospatial Analysis, Medical Informatics, Health Systems Research.

Introduction

Contemporary healthcare research increasingly relies on data-driven approaches to understand disease patterns, optimize emergency response systems, and improve patient outcomes. Akerke Chayakova’s research aligns with these priorities by examining emergency healthcare utilization, environmental influences on health events, and the integration of innovative technologies into clinical practice.[3]

Research Profile

Her scholarly profile includes publications addressing cardiovascular emergencies, traumatic injury response systems, COVID-19 healthcare management, and the role of artificial intelligence in disease screening. These studies employ retrospective analyses, geospatial methodologies, and health data evaluation techniques to investigate factors affecting healthcare delivery and patient management.[4]

Research Contributions

  • Investigation of emergency medical service utilization and transport decision-making in ischemic heart disease.
  • Analysis of urban environmental factors influencing traumatic injury response patterns.
  • Assessment of emergency medical services during the COVID-19 pandemic.
  • Evaluation of artificial intelligence applications in periodontal disease diagnosis and screening.

Publications

  • Beyond Clinical Acuity: Cardiac Comorbidity and Complication Profiles and the Prehospital Hospitalization/Transport Decision in Ischemic Heart Disease (Healthcare, 2026).
  • Urban Environmental Determinants and Spatiotemporal Patterns of Emergency Medical Service Response to Traumatic Injuries (IJERPH, 2026).
  • Modern Approaches to the Integration of Artificial Intelligence into the Diagnosis and Screening of Periodontal Diseases (2026).
  • Geospatial and Temporal Analysis of Emergency Medical Services during the COVID-19 Pandemic (2025).

Research Impact

According to the available Scopus author profile, Akerke Chayakova has accumulated scholarly visibility through indexed publications, citations, and an emerging citation record. Her research contributes to public health evidence, healthcare planning, emergency response optimization, and digital health innovation. The integration of epidemiological analysis with practical healthcare challenges demonstrates the translational relevance of her work.[1]

Award Suitability

The Innovative Research Award recognizes researchers who demonstrate originality, scientific rigor, and meaningful contributions to their disciplines. Akerke Chayakova’s investigations into emergency medical systems, healthcare analytics, public health challenges, and artificial intelligence applications in medicine align with the objectives of innovation-focused academic recognition programs. Her interdisciplinary approach highlights the practical value of research in improving healthcare outcomes and system efficiency.[5]

Conclusion

Akerke Chayakova has established a developing research profile centered on medicine and health sciences. Her work contributes to the understanding of emergency healthcare systems, public health management, and emerging digital healthcare solutions. The combination of methodological analysis and healthcare application supports her recognition within contemporary medical research environments.

References

  1. Elsevier. (n.d.). Scopus author details: Akerke Chayakova, Author ID 57226888892. Scopus.
    https://www.scopus.com/pages/authors/57226888892
  2. Healthcare. (2026). Beyond Clinical Acuity: Cardiac Comorbidity and Complication Profiles.
    https://doi.org/10.3390/healthcare14152308
  3. International Journal of Environmental Research and Public Health. (2026). Urban Environmental Determinants and Spatiotemporal Patterns.
    https://doi.org/10.3390/ijerph23040434
  4. Journal of Health Development. (2026). Artificial Intelligence in Diagnosis and Screening of Periodontal Diseases.
    https://doi.org/10.32921/2663-1776-2026-61-1-jhd059
  5. Portuguese Journal of Public Health. (2025). Geospatial and Temporal Analysis of Emergency Medical Services during the COVID-19 Pandemic.
    https://doi.org/10.1159/000549009

Xiaochun Zhang | Health Professions | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Xiaochun Zhang
Nanjing University of Chinese Medicine, China

Xiaochun Zhang
Affiliation Nanjing University of Chinese Medicine
Country China
Scopus ID 56482687800
Documents 34
Citations 627
h-index 11
Subject Area Health Professions
Event International Forensic Scientist Awards
ORCID 0009-0000-3644-5333

The Innovative Research Award recognizes researchers whose scholarly activities contribute to the advancement of scientific knowledge and evidence-based practice. Xiaochun Zhang, affiliated with Nanjing University of Chinese Medicine, has established a research profile spanning gastrointestinal health, oncology, rehabilitation medicine, inflammatory disorders, and translational medical science. Through peer-reviewed publications and interdisciplinary investigations, Zhang has contributed to emerging areas of clinical and biomedical research while maintaining active engagement with contemporary healthcare challenges.[1]

Abstract

Xiaochun Zhang’s scholarly activities demonstrate a sustained commitment to advancing health sciences through clinical investigation, translational medicine, and therapeutic innovation. Research outputs encompass colorectal cancer, inflammatory bowel disease, osteoporosis risk prediction, postoperative gastrointestinal recovery, and pelvic floor rehabilitation. The body of work reflects a multidisciplinary perspective that integrates clinical evidence, biomedical mechanisms, and predictive healthcare strategies.[2]

Keywords

Translational Medicine; Colorectal Cancer; Traditional Chinese Medicine; Osteoporosis Prediction; Pelvic Floor Rehabilitation; Inflammatory Disorders; Clinical Research; Health Professions.

Introduction

Healthcare research increasingly depends on interdisciplinary approaches capable of linking molecular mechanisms with patient-centered outcomes. Xiaochun Zhang’s academic activities align with this objective through studies that examine disease mechanisms, therapeutic interventions, and predictive clinical models. These efforts contribute to ongoing discussions regarding precision medicine and evidence-informed healthcare delivery.[3]

Research Profile

Zhang obtained medical training at Nanjing University of Chinese Medicine and maintains academic affiliations within the institution. Additional scholarly identifiers include ORCID, SciProfiles, and Loop profile records. Research interests encompass oncology, gastrointestinal surgery, inflammatory disease management, rehabilitation medicine, and clinical epidemiology.[1]

Research Contributions

  • Investigation of lipid metabolic reprogramming in colorectal cancer liver metastasis and anti-PD-1 therapy enhancement.
  • Development of predictive nomograms for osteoporosis risk assessment in rheumatoid arthritis patients.
  • Evaluation of rehabilitation interventions for postpartum stress urinary incontinence recovery.
  • Studies examining inflammatory and mitochondrial responses in experimental colitis.
  • Reviews exploring gut vascular barrier restoration as a therapeutic target in postoperative ileus.

Publications

Selected publications include articles in Phytomedicine, Frontiers in Medicine, Current Issues in Molecular Biology, World Journal of Gastrointestinal Surgery, and Acupuncture & Electro-Therapeutics Research. These works address therapeutic optimization, predictive healthcare tools, inflammatory disease biology, and postoperative recovery strategies.[4]

Research Impact

According to available scholarly metrics, the researcher has accumulated 627 citations and an h-index of 11 across indexed publications. These indicators suggest sustained academic visibility and engagement within relevant scientific communities. The integration of clinical observations with mechanistic research enhances the translational value of the published work.[5]

Award Suitability

The Innovative Research Award emphasizes originality, scientific rigor, and measurable contribution to knowledge development. Zhang’s portfolio demonstrates engagement with clinically relevant questions while employing multidisciplinary methodologies. The combination of publication productivity, citation performance, and translational relevance supports consideration for recognition within the International Forensic Scientist Awards framework.[6]

Conclusion

Xiaochun Zhang represents a contemporary researcher whose work bridges biomedical discovery and clinical application. Through contributions spanning oncology, inflammatory disease research, rehabilitation medicine, and predictive healthcare analytics, the researcher has established a record of scholarly activity aligned with the objectives of innovation-driven scientific recognition programs.

References

  1. ORCID. (n.d.). Xiaochun Zhang researcher profile.
    https://orcid.org/0009-0000-3644-5333
  2. Zhang, X. (2026). Neferine-enhanced Shenling Baizhu Tang potentiates anti-PD-1 therapy in colorectal cancer liver metastasis.
    DOI: https://doi.org/10.1016/j.phymed.2026.158236
  3. Zhang, X. (2026). Development and validation of a nomogram predicting osteoporosis risk in rheumatoid arthritis.
    DOI: https://doi.org/10.3389/fmed.2026.1747090
  4. Zhang, X. (2026). Resistance Training Complements Anti-TNF Therapy in DSS-Induced Colitis.
  5. Elsevier. (n.d.). Scopus author details: Xiaochun Zhang, Author ID 56482687800.
    https://www.scopus.com/authid/detail.uri?authorId=56482687800
  6. World Journal of Gastrointestinal Surgery. (2026). Repairing the impaired gut vascular barrier as a novel therapeutic target for prolonged postoperative ileus.
    DOI: https://doi.org/10.4240/wjgs.v18.i4.117318

Yury Kustov | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Best Researcher Award

Yury Kustov
Peoples’ Friendship University of Russia
Yury Kustov
Affiliation Peoples’ Friendship University of Russia
Country Russia
Scopus ID 58987836800
Documents 5
Citations 4
h-index 1
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0009-0002-4859-4322

Yury Kustov is a researcher affiliated with the Peoples’ Friendship University of Russia whose scholarly work focuses on medicine, pharmacovigilance, drug safety, pulmonary fibrosis, and clinical pharmacology. His recent publications examine adverse drug reactions, pediatric pharmacotherapy, pulmonary complications, and systematic reviews related to pharmacokinetics and post-COVID-19 outcomes. Through contributions indexed in Scopus, Kustov has participated in interdisciplinary investigations concerning patient safety and evidence-based medical analysis.[1] His profile reflects active engagement in healthcare-related research areas associated with pharmacological monitoring and clinical risk assessment.[2]

Abstract

The academic contributions of Yury Kustov are associated with contemporary clinical medicine and pharmacovigilance research. His published studies explore adverse drug reactions, pulmonary fibrosis, antibiotic safety, and pediatric therapeutic outcomes. Several investigations emphasize spontaneous report database analysis and systematic reviews in order to improve healthcare monitoring and pharmacological safety standards.[3] These contributions support broader scientific discussions regarding medication-related complications and patient-centered clinical evaluation.

Keywords

Pharmacovigilance, Clinical Pharmacology, Pulmonary Fibrosis, Pediatric Medicine, Drug Safety, Post-COVID Research, Pharmacokinetics, Medicine and Health Sciences.

Introduction

The advancement of modern healthcare increasingly depends on pharmacological safety assessment and evidence-based therapeutic monitoring. Researchers involved in pharmacovigilance contribute to the identification of adverse reactions and clinical complications linked to pharmaceutical interventions. Yury Kustov has participated in this research landscape through studies addressing antibacterial drug reactions, pulmonary fibrosis, and pediatric medicine.[4] His publications demonstrate engagement with healthcare datasets and clinical literature reviews that contribute to scientific understanding of treatment-related risks.

Research Profile

Kustov’s academic profile includes journal articles and conference publications indexed through Scopus and related scholarly databases. His research areas include pharmacokinetics in chronic heart failure, pulmonary fibrosis associated with pharmacotherapy, and pediatric antibacterial drug safety. The researcher has also examined Stevens–Johnson syndrome and toxic epidermal necrolysis using spontaneous reporting systems.[5] These studies align with medical efforts to improve treatment evaluation and patient safety methodologies.

Research Contributions

  • Analysis of fluoroquinolone safety in pediatric populations through pharmacovigilance database studies.
  • Systematic review research concerning pharmacokinetic alterations in chronic heart failure patients.
  • Investigations into pulmonary fibrosis and post-COVID-19 pharmacotherapy outcomes.
  • Evaluation of spontaneous adverse drug reaction reports linked to antibacterial medications.

Publications

  • “Safety of fluoroquinolones in pediatric patients: Pharmacovigilance database analysis”
  • “Pharmacokinetic Alterations in Patients with Chronic Heart Failure: A Systematic Review”
  • “Drug-Induced Pulmonary Fibrosis: National Database Analysis”

Research Impact

The research contributions of Yury Kustov demonstrate relevance to healthcare monitoring, medication safety assessment, and evidence-based pharmacology. By utilizing systematic reviews and spontaneous report analyses, his studies contribute to discussions surrounding adverse drug reaction surveillance and therapeutic evaluation. Such research supports clinicians, pharmacologists, and healthcare researchers seeking to understand treatment-related complications in vulnerable patient populations.

Award Suitability

Yury Kustov’s publication record and involvement in pharmacovigilance-related medical studies align with the objectives of the International Forensic Scientist Awards. His focus on drug safety analysis, pulmonary complications, and healthcare risk assessment reflects scholarly engagement with medically significant challenges. The integration of database-driven clinical analysis and systematic review methodologies further demonstrates research activity associated with modern healthcare science and patient protection initiatives.

Conclusion

Yury Kustov has contributed to medicine and health sciences through publications examining pharmacovigilance, pulmonary fibrosis, clinical pharmacology, and pediatric drug safety. His academic profile reflects ongoing participation in evidence-based medical research and healthcare monitoring studies. Through indexed scholarly outputs and DOI-linked publications, his work contributes to the broader scientific understanding of pharmaceutical safety and patient-centered clinical investigation.

References

  1. Elsevier. (n.d.). Scopus author details: Yury Kustov, Author ID 58987836800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58987836800
  2. ORCID. (n.d.). Yury Kustov ORCID profile.
    https://orcid.org/0009-0002-4859-4322
  3. Kustov, Y. (2026). Safety of fluoroquinolones in pediatric patients: Pharmacovigilance database analysis.
    https://doi.org/10.1177/09246479251398995
  4. Kustov, Y. (2025). Pharmacokinetic Alterations in Patients with Chronic Heart Failure: A Systematic Review.
    https://doi.org/10.3390/ijms26199495
  5. Kustov, Y. (2024). Drug-Induced Pulmonary Fibrosis: National Database Analysis.
    https://doi.org/10.3390/biomedicines12122650

Hong Zhang | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Hong Zhang
University of Texas Southwestern Medical Center, United States
Hong Zhang
Affiliation University of Texas Southwestern Medical Center
Country United States
Scopus ID 57192482890
Documents 28
Citations 550
h-index 13
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0003-3056-0343

Hong Zhang, is an orthopedic surgeon, biomedical innovator, and musculoskeletal research specialist affiliated with the University of Texas Southwestern Medical Center and Texas Scottish Rite Hospital for Children in Dallas, Texas. His research activities focus primarily on pediatric spinal deformities, growth modulation, spinal instrumentation development, scoliosis correction technologies, and minimally invasive spinal surgery. Through a combination of clinical orthopedic expertise and translational biomedical engineering, Zhang has contributed to the development of novel surgical systems and patented technologies intended to improve the treatment of severe spinal deformities and early-onset scoliosis.[1]

As Director of the Division of Creative Innovations within the Seay Center for Musculoskeletal Research, Zhang has overseen multidisciplinary investigations involving experimental spine biomechanics, orthopedic implant design, pediatric spine growth modulation, and surgical correction strategies. His publication record, citation metrics, and patent portfolio demonstrate sustained scholarly engagement in orthopedic research and spinal deformity innovation.[2]

Abstract

Hong Zhang is recognized for contributions to orthopedic surgery research, spinal deformity correction technologies, and pediatric musculoskeletal innovation. His work has focused on improving surgical outcomes for severe scoliosis and kyphosis through biomechanical research, implant design, and translational clinical investigations. Zhang has also contributed to orthopedic device development through multiple United States patents related to spinal correction systems and stabilization technologies.[3] His scholarly publications in journals such as Spine Deformity, European Spine Journal, and Seminars in Spine Surgery highlight continued engagement in experimental spine research and orthopedic innovation.[4]

Keywords

Orthopedic Surgery, Pediatric Scoliosis, Spinal Deformity, Spine Research, Musculoskeletal Innovation, Early-Onset Scoliosis, Orthopedic Instrumentation, Growth Modulation, Biomedical Engineering, Pediatric Orthopedics

Introduction

The field of pediatric spinal deformity research requires coordinated advances in biomechanics, surgical techniques, implant engineering, and long-term clinical evaluation. Hong Zhang has contributed to this interdisciplinary area through research addressing early-onset scoliosis, thoracic deformities, vertebral correction systems, and growth-preserving spinal interventions. His investigations combine experimental orthopedic science with clinically applicable instrumentation design.[5]

Zhang obtained his medical degree from Tianjin Medical University in China and completed orthopedic surgery training at Tianjin Hospital before undertaking international orthopedic research and clinical scholarship programs in Italy and the United States. Since joining the University of Texas Southwestern Medical Center and Texas Scottish Rite Hospital for Children, he has participated in numerous collaborative orthopedic research initiatives focused on pediatric spine disorders and surgical innovation.[6]

Research Profile

Hong Zhang currently serves as Director of the Division of Creative Innovations within the Center of Excellence in Spine Research at the Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, Texas. He also holds the academic position of Associate Professor in the Department of Orthopaedic Surgery at the University of Texas Southwestern Medical Center.[1]

His research profile demonstrates sustained focus on pediatric spinal deformities, including early-onset scoliosis, thoracic kyphosis, spinal growth modulation systems, minimally invasive thoracoscopic procedures, and spinal instrumentation biomechanics. Zhang’s work frequently integrates engineering methodologies, experimental spine models, and translational orthopedic device development.[7]

  • Early-onset scoliosis and pediatric spine growth research
  • Orthopedic implant and spinal instrumentation development
  • Growth modulation systems for spinal correction
  • Biomechanical evaluation of spinal deformity devices
  • Experimental and translational musculoskeletal research
  • Minimally invasive spinal surgical technologies

Research Contributions

Zhang has contributed extensively to the development of innovative spinal correction systems intended for severe spinal deformities and pediatric scoliosis treatment. His patented orthopedic technologies include spinal rod reduction devices, pedicle screw systems, stabilization fasteners, and hinge-link spinal correction devices designed to improve alignment control and surgical correction efficiency.[8]

A significant component of his recent research involves the development of growth modulation systems using dynamic spinal correction approaches. Experimental investigations involving porcine models and three-dimensional simulation technologies have supported the evaluation of biomechanical effectiveness and safety profiles of novel correction systems.[9]

Zhang’s work on vertebral column resection systems and angular kyphosis reduction devices has also contributed to understanding correction strategies for severe thoracic spinal deformities. These studies have explored both implant mechanics and surgical feasibility in complex deformity correction procedures.[10]

  • Development of hinge-link spinal correction technologies
  • Novel uniplanar correction systems for angular kyphosis
  • Dynamic scoliosis correction and growth modulation research
  • Biomechanical studies of pediatric spinal instrumentation
  • Experimental orthopedic implant design and testing

Publications

Hong Zhang has authored and co-authored multiple peer-reviewed scientific publications addressing pediatric scoliosis, thoracic deformity correction, spine biomechanics, and orthopedic surgical technologies.[11]

  1. Zhang H, Lima JM, Jo CH, and Sucato DJ. The closing triradiate cartilage stage identifies accelerated curve progression in idiopathic scoliosis. Spine Deformity (2026).
  2. Zhang H, Ross D, and Sucato DJ. Evaluation of a novel angular kyphosis reduction device for vertebral column resection in severe angular kyphosis. European Journal of Orthopaedic Surgery & Traumatology (2026).
  3. Zhang H, Ross D, and Sucato DJ. A new uniplanar correction strategy for severe thoracic kyphosis: concept, device design, and simulation with a 3D-printed model. Spine Deformity (2026).
  4. Zhang H, Niese B, and Sucato DJ. Growth modulation and dynamic correction of early-onset thoracic scoliosis using a PEEK spring rib plate system: a porcine model study. Spine Deformity (2026).
  5. Brooks JT, Carron CJ, Zhang H, and Sucato DJ. Going anterior for the surgical management of pediatric scoliosis: Indications and technique pearls. Seminars in Spine Surgery (2025).

Research Impact

According to available Scopus metrics, Zhang has produced 28 indexed scholarly documents with approximately 550 citations and an h-index of 13, reflecting measurable academic influence within orthopedic surgery and musculoskeletal research communities.[1] His research output has contributed to the scientific understanding of pediatric spinal deformities, spinal growth dynamics, and orthopedic implant biomechanics.

His work has also received recognition through national and international awards, including the John H. Moe Award for Best Basic Science presented by the Scoliosis Research Society in both 2009 and 2010.[12] Additional grant support from organizations such as the Pediatric Orthopedic Society of North America and the Scoliosis Research Society further reflects the relevance of his investigations within pediatric orthopedic research.

Award Suitability

Hong Zhang’s academic profile aligns with the objectives of the Innovative Research Award due to his sustained contributions to orthopedic surgery innovation, spinal deformity correction technologies, and translational pediatric spine research. His work demonstrates interdisciplinary integration between clinical orthopedic practice, biomechanical engineering, and experimental medical device development.[8]

The combination of peer-reviewed publications, patented surgical systems, funded research projects, and international scientific recognition supports consideration of Zhang’s contributions within the field of medicine and health sciences. His focus on improving treatment strategies for complex pediatric spinal conditions reflects ongoing commitment to clinically relevant biomedical innovation.[10]

Conclusion

Hong Zhang has established a scholarly and clinical research profile centered on pediatric orthopedic innovation and spinal deformity correction. Through collaborative orthopedic research, patented instrumentation systems, and translational experimental studies, he has contributed to the advancement of spinal surgery technologies and pediatric musculoskeletal care. His publication history, research awards, and scientific contributions collectively support recognition within international academic and biomedical innovation platforms.[11]

References

  1. Elsevier. (n.d.). Scopus author details: Hong Zhang, Author ID 57192482890. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57192482890
  2. University of Texas Southwestern Medical Center. (n.d.). Faculty and research profile information for Hong Zhang.
  3. United States Patent and Trademark Office. (2010). Method for the Correction of Spinal Deformities Using Rod-Plate Anterior System.
  4. Springer Nature. (2026). Spine Deformity journal publications authored by Hong Zhang.
  5. Zhang H, Ross D, and Sucato DJ. (2026). Evaluation of a novel angular kyphosis reduction device for vertebral column resection in severe angular kyphosis.
    https://doi.org/10.1007/s00590-026-04778-y
  6. Texas Scottish Rite Hospital for Children. (n.d.). Seay Center for Musculoskeletal Research profile.
  7. Zhang H, Niese B, and Sucato DJ. (2026). Growth modulation and dynamic correction of early-onset thoracic scoliosis using a PEEK spring rib plate system.
    https://doi.org/10.1007/s43390-026-01284-3
  8. United States Patent and Trademark Office. (2023). Hinge-Link Spinal Correction Device and Method.
  9. Wang XB, Zhang H, and Sucato DJ. (2023). Unilateral thoracic spinal nerve resection creates early onset thoracic scoliosis in an immature porcine model.
    https://doi.org/10.1007/s00586-023-07804-3
  10. Zhang H, Ross D, and Sucato DJ. (2024). A Novel Uniplanar Clamp-Hinge Correction System for Vertebral Column Resection of Severe Angular Kyphosis.
    https://doi.org/10.1007/s43390-023-00770-2
  11. Elsevier. (n.d.). Publication and citation metrics for Hong Zhang in orthopedic research.
  12. Scoliosis Research Society. (2010). John H. Moe Award for Best Basic Science.

Anna Sójka-Makowska | Medicine and Health Sciences | Forensic Scientist of the Year Award

Published on by Forensic Scientist Awards

Forensic Scientist of the Year Award

Anna Sójka-Makowska
Poznan University of Medical Sciences, Poznan, Poland
Anna Sójka-Makowska
Affiliation Poznan University of Medical Sciences
Country Poland
Scopus ID 57196022239
Documents 5
Citations 165
h-index 5
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0002-0193-0491

Anna Sójka-Makowska is associated with the Poznan University of Medical Sciences in Poland and has contributed to interdisciplinary clinical research involving temporomandibular disorders, neurophysiological diagnostics, dentistry, and related biomedical sciences. Her scholarly activities include investigations into temporomandibular dysfunctions, headache disorders, neuroendocrine biomarkers, and patient-centered therapeutic methodologies within modern dental and medical practice.[1] Her publication profile reflects continued academic engagement in diagnostic sciences and clinical assessment methodologies relevant to forensic and health-related research domains.[2]

Abstract

The professional activities of Anna Sójka-Makowska demonstrate sustained involvement in clinical and diagnostic investigations within dentistry and biomedical sciences. Her work has addressed temporomandibular disorders, neurophysiological examinations, headache-associated dysfunctions, and biomarker-oriented clinical studies. Through peer-reviewed publications and collaborative research projects, she has contributed to evidence-based methodologies that support patient diagnostics and interdisciplinary healthcare research.[3] The combination of clinical relevance and analytical rigor supports recognition within the framework of the Forensic Scientist of the Year Award.

Keywords

Temporomandibular Disorders, Dentistry, Neurophysiology, Biomarkers, Clinical Diagnostics, Prosthodontics, Oral Health Research, Forensic Medicine, Medical Sciences, Temporomandibular Joint Disorders.

Introduction

Research involving temporomandibular disorders and associated neurological or psychological conditions represents an important area within contemporary clinical medicine. Anna Sójka-Makowska has participated in studies examining the relationship between temporomandibular dysfunctions, headache disorders, stress-related conditions, and neuroendocrine biomarkers.[4] Her investigations have contributed to the understanding of diagnostic frameworks such as DC/TMD and related clinical assessment methodologies applied in patient-centered healthcare environments.[5]

The interdisciplinary nature of her research reflects collaboration across dentistry, neurology, behavioral sciences, and rehabilitation-oriented medicine. Such integration of clinical knowledge and analytical approaches aligns with the objectives of academic recognition programs focused on healthcare innovation and applied scientific contributions.

Research Profile

Anna Sójka-Makowska serves within the academic and clinical environment of Poznan University of Medical Sciences. Her research profile includes publications in journals related to craniofacial medicine, behavioral sciences, prosthodontics, and neurophysiology. She has participated in investigations concerning temporomandibular disorders among adolescents and adults, clinical examination protocols, patient satisfaction in prosthodontic treatment, and biomarker studies associated with neurological conditions.[6]

According to indexed academic records, her Scopus profile reports measurable citation activity and scholarly visibility within medical and dental sciences.[1] Her work demonstrates consistent involvement in clinically applicable research supported by peer-reviewed dissemination and interdisciplinary cooperation.

Research Contributions

A significant component of Anna Sójka-Makowska’s contributions involves the study of temporomandibular disorders and their relationship with neurological, psychological, and physiological indicators. Her studies have explored stress manifestations, anxiety, and psychosocial influences associated with temporomandibular dysfunctions in clinical populations.[7]

Recent investigations have focused on biomarkers including Nesfatin-1 and Ghrelin/GOAT in adolescent headache and epilepsy-related studies. These projects contribute to ongoing scientific discussions concerning neuroendocrine regulation, pain mechanisms, and diagnostic biomarkers relevant to neurological and craniofacial disorders.[8]

  • Clinical investigations into temporomandibular disorders and patient diagnostics.
  • Research on neuroendocrine biomarkers associated with headache and epilepsy conditions.
  • Comparative studies involving DC/TMD and RDC/TMD diagnostic methodologies.
  • Interdisciplinary collaboration linking dentistry, neurology, and behavioral sciences.
  • Peer-reviewed dissemination in clinical and biomedical journals.

Publications

Selected scholarly publications associated with Anna Sójka-Makowska include peer-reviewed articles, literature reviews, conference papers, and clinical studies relevant to dentistry and medical sciences.[9]

  • Is there a relationship between psychological factors and TMD? — Brain and Behavior (2019). DOI:
  • Temporomandibular disorders in adolescents with headache — Advances in Clinical and Experimental Medicine (2018). DOI:
  • Relations between the results of complex clinical and neurophysiological examinations in patients with temporomandibular disorders symptoms — CRANIO (2017). DOI:
  • Comparison of Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) and RDC/TMD — IRONS Journal (2016).
  • Nesfatin-1 and Ghrelin/GOAT as Potential Biomarkers in Adolescent Headache with Temporomandibular Disorders — Journal of Medical Science (2025).

Research Impact

The academic impact of Anna Sójka-Makowska’s work is reflected through citation activity, collaborative publications, and participation in clinically oriented biomedical research. Her studies have addressed practical diagnostic challenges within dentistry and craniofacial medicine while also contributing to broader discussions involving pain disorders, neurophysiology, and behavioral health.[10]

Research concerning temporomandibular disorders and neuroendocrine biomarkers carries importance for both diagnostic sciences and patient management frameworks. The integration of clinical examinations with evidence-based analysis supports scientific advancement within healthcare disciplines and contributes to ongoing improvements in interdisciplinary diagnostic methodologies.

Award Suitability

Anna Sójka-Makowska demonstrates professional and academic characteristics relevant to the objectives of the Forensic Scientist of the Year Award. Her involvement in diagnostic research, clinical methodologies, and biomarker-based investigations illustrates a commitment to scientific rigor and interdisciplinary healthcare research.[11]

The combination of indexed publications, citation visibility, collaborative investigations, and contributions to patient-oriented diagnostics supports consideration for scholarly recognition. Her research profile reflects continued engagement with scientifically relevant issues that intersect clinical medicine, dentistry, neurophysiology, and evidence-based diagnostic practice.

Conclusion

Anna Sójka-Makowska has established a research portfolio centered on temporomandibular disorders, clinical diagnostics, neurophysiological assessment, and interdisciplinary medical investigations. Her scholarly contributions within dentistry and health sciences demonstrate consistency in research activity and participation in clinically applicable scientific studies.[12] Through publications, collaborative projects, and analytical clinical research, she represents a suitable candidate for recognition within international scientific award frameworks.

References

  1. Elsevier. (n.d.). Scopus author details: Anna Sójka-Makowska, Author ID 57196022239. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57196022239
  2. ORCID. (n.d.). Anna Sójka-Makowska ORCID Profile.
    https://orcid.org/0000-0002-0193-0491
  3. Sójka, A., et al. (2017). Relations between the results of complex clinical and neurophysiological examinations in patients with temporomandibular disorders symptoms. CRANIO.
    https://www.tandfonline.com/doi/full/10.1080/08869634.2017.1290907
  4. Sójka, A., et al. (2018). Temporomandibular disorders in adolescents with headache. Advances in Clinical and Experimental Medicine.
    https://www.researchgate.net/publication/323644581_Temporomandibular_disorders_in_adolescents_with_headache
  5. Sójka, A., Pilarski, J., & Hędzelek, W. (2021). Description of the methodology for clinical examination of patients with temporomandibular disorders according to DC/TMD classification. Dental Forum.
  6. ResearchGate. (n.d.). Anna Sójka publication and research overview.
  7. Sójka, A., et al. (2019). Is there a relationship between psychological factors and TMD? Brain and Behavior.
  8. Sójka, A., et al. (2025). Nesfatin-1 and Ghrelin/GOAT as Potential Biomarkers in Adolescent Headache with Temporomandibular Disorders. Journal of Medical Science.
  9. Sójka, A., et al. (2016). Comparison of Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) and RDC/TMD in Evaluation of Temporomandibular Disorders. IRONS Journal.
  10. Poznan University of Medical Sciences. (n.d.). Department and Clinic of Prosthodontics research activities.
  11. International Forensic Scientist Awards. (n.d.). Award recognition and academic excellence framework.
  12. Sójka, A., et al. (2026). Comparison of the effectiveness of psycho-behavioral-relaxation and occlusal splint therapy in the treatment of myalgia. Dental and Medical Problems.

Haifang Du | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Haifang Du | Medicine and Health Sciences | Best Researcher Award

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine | China

Dr. Haifang Du is an Assistant Researcher at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine and a researcher at the Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China, specializing in targeted drug delivery, exosome technology, and natural product-based cancer therapy. She earned her Ph.D. in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences in 2019 and completed a postdoctoral fellowship between 2021 and 2023, focusing on advanced precision therapeutics. Previously, she managed research and development projects in the biotechnology sector from 2019 to 2020. Dr. Haifang Du has led six research projects, including three national and provincial initiatives, and continues to explore molecular strategies for bladder cancer, colon cancer, and rheumatoid arthritis therapy. Her scholarly output includes 13 Scopus-indexed publications, with a total of 54 citations and an h-index of 4, six of which she authored as the first or corresponding author. She has three patents under process related to exosome-mediated drug delivery systems. Among her notable works are Exosome-mediated delivery of natural compounds for cancer therapy (Journal of Controlled Release, 2021, cited by 32 articles), Targeted exosome-based therapeutics in oncology (Theranostics, 2022, cited by 24 articles), and Natural product-based immunometabolic interventions in cancer therapy (Frontiers in Pharmacology, 2023, cited by 18 articles). Her research excellence earned her the Hunan Provincial TCM Science and Technology Third Prize (2023). Through her continuous contributions to translational medicine, Dr. Haifang Du is advancing precision drug delivery, enhancing therapeutic efficacy, and promoting the integration of traditional medicine with modern biomedical science to achieve impactful innovation in healthcare.

Profile: Scopus

Featured Publications

  • Du, H., Yu, Y., Yan, X., & Zhang, P. (2025). Identification of chemical constituents, absorbed prototype components, and quality control of Traditional Chinese Medicine formula B granules. Journal of Pharmaceutical and Biomedical Analysis, 268, 117176. https://doi.org/10.1016/j.jpba.2025.117176

  • Huang, X., Wang, X., He, Z., Huang, Y., Hu, B., Chen, W., & Du, H. (2025). Mechanisms, clinical trials, and new treatments for BCG‐unresponsive in nonmuscle invasive bladder cancer. Cancer Medicine, 14(18). https://doi.org/10.1002/cam4.71243

  • Chen, Z., Guo, X., Wu, S., Wang, M., Wu, J., Du, H., Liang, H., Huang, R., & Huang, Q. (2025). Huayu Tongbi formula attenuates rheumatoid arthritis by inhibiting the HIF1A/VEGFA/ANGPT axis and suppressing angiogenesis. Phytomedicine, 139, 156479. https://doi.org/10.1016/j.phymed.2025.156479

Mario Troisi | Medicine | Excellence in Innovation

Published on by Forensic Scientist Awards

Dr. Mario Troisi | Medicine | Excellence in Innovation

MD | University of Naples Federico II | Italy

Mario Troisi, MD, is an accomplished ophthalmologist and senior resident at the University of Naples Federico II, Italy. He graduated with distinction from the University of Salerno in Medicine and Surgery (110/110 cum laude). Dr. Troisi specializes in ocular surface diseases and corneal surgeries and has participated in numerous prestigious international fellowships, including a corneal fellowship at the University of Brescia and a cataract surgery program in Egypt. A prolific researcher and speaker, he has presented at over 30 national and international conferences. In 2024, Dr. Troisi received the ESCRS Trainee Bursary and the EVER Andrzej Grzybowski Award, highlighting his outstanding contributions to ophthalmology.

Profile

Orcid

Scopus

Google Scholar

Strengths for the Awards

  • Innovative Research Contributions:
    • Dr. Troisi has an impressive portfolio of peer-reviewed publications in high-impact journals. His work emphasizes cutting-edge methodologies like scanning electron microscopy (SEM) for ocular surface diseases, offering diagnostic and therapeutic innovations.
    • Topics such as ocular surface health biomarkers, keratitis diagnosis, and dry-eye treatment advancements showcase his forward-thinking research with potential for significant clinical impact.
  • Diverse Clinical Expertise:
    • His experience spans ophthalmology subspecialties, including cataract surgery, ocular surface diseases, and advanced imaging techniques like SD-OCT and fluorescein angiography.
    • He has engaged in multiple surgical fellowships and clinical trials, demonstrating hands-on application of his research.
  • Recognition and Awards:
    • Dr. Troisi has won prestigious accolades, such as the ESCRS Trainee Bursary and the Andrzej Grzybowski EVER Award in 2024. These reflect his contributions to ophthalmology and innovative research initiatives.
    • His active participation in international conferences as a speaker, presenter, and award finalist further highlights his ability to disseminate knowledge and inspire innovation.
  • Multidisciplinary Education:
    • His educational qualifications, including Master’s degrees in Aesthetic Medicine and Biostatistics, demonstrate a strong foundation in both clinical practice and statistical rigor—critical for conducting impactful research.

Education 🎓📚

Dr. Troisi’s academic journey began with a Scientific High School Diploma, achieved with honors in 2012. He earned his Master’s degree in Medicine and Surgery at the University of Salerno in 2019 (110/110 cum laude). His global outlook led him to an exchange program at Ivane Javakhishvili State University in Georgia. Furthering his expertise, he pursued residencies in ophthalmology, advanced surgical fellowships, and master’s degrees in aesthetic medicine (2023) and biostatistics for clinical research (2024). He also completed specialized training in ophthalmic echography and clinical cornea fellowships.

Professional Experience 💼

Since 2020, Dr. Troisi has worked as a medical practitioner across Salerno and Naples, Italy. His expertise spans internal medicine, ophthalmology, and emergency care. Notably, he contributed to local COVID-19 vaccination campaigns and gained hands-on surgical experience in cataract surgery, corneal cross-linking, and intravitreal injections. Currently, he is a senior resident at the University of Naples Federico II Eye Clinic, specializing in ocular surface diseases and advanced surgical interventions.

Research Interests On Medicine 🔬

Dr. Troisi is deeply involved in research on ocular surface diseases, corneal pathologies, and innovative ophthalmic treatments. His work utilizes advanced techniques such as scanning electron microscopy (SEM) to analyze conjunctival microvilli and evaluate new tear substitutes. His research focuses on clinical trials and translational medicine to improve patient outcomes in ophthalmology.

Awards and Recognitions 🏆🌟

Dr. Troisi has received multiple accolades for his contributions to ophthalmology. In 2024, he won the ESCRS Trainee Bursary and the EVER Andrzej Grzybowski Award. Additionally, his photography and research presentations have been recognized at international conferences, such as winning the “Eye Beyond the Surface” competition at the 27th EVER Congress.

Publications 📑📘

  • Comparative evaluation of antimicrobial, antiamoebic, and antiviral efficacy of ophthalmic formulations
    • Authors: C. Caruso, D. Eletto, A. Tosco, M. Pannetta, F. Scarinci, M. Troisi, A. Porta
    • Year: 2022
    • Citations: 12
  • Ocular surface infection by SARS-CoV-2 in COVID-19 pneumonia patients admitted to sub-intensive unit: preliminary results
    • Authors: M. Troisi, C. Zannella, S. Troisi, M. De Bernardo, M. Galdiero, G. Franci, …
    • Year: 2022
    • Citations: 12
  • Tear liquid for predictive diagnosis of Alzheimer’s disease
    • Authors: S. Del Prete, D. Marasco, R. Sabetta, A. Del Prete, F. Z. Marino, R. Franco, …
    • Year: 2021
    • Citations: 10
  • Scanning Electron Microscopy of Conjunctival Scraping: Our Experience in the Diagnosis of Infectious Keratitis with Negative Culture Tests
    • Authors: M. Troisi, S. Del Prete, S. Troisi, D. Marasco, C. Costagliola
    • Year: 2023
    • Citations: 5
  • Correlative microscopy (CLEM) of tarsal conjunctival scraping: A new opportunity in the diagnosis of microbial keratitis
    • Authors: M. Troisi, S. Del Prete, S. Troisi, D. Marasco, C. Costagliola
    • Year: 2024
    • Citations: 3
  • Utility of Scanning Electron Microscopy (SEM) for Suspected Microbial Keratoconjunctivitis Unresponsive to Broad-Spectrum Antibiotic Therapy
    • Authors: M. Troisi, S. Del Prete, S. Troisi, M. V. Turco, V. Turco
    • Year: 2023
    • Citations: 3
  • Scanning Electron Microscopy (SEM) Evaluation of the Ultrastructural Effects on Conjunctival Epithelial Cells of a New Multiple-Action Artificial Tear Containing Cross-Linked Hyaluronic Acid
    • Authors: M. Troisi, S. Del Prete, S. Troisi, D. Marasco, M. Rinaldi, C. Costagliola
    • Year: 2024
    • Citations: 2
  • Scanning electron microscopy (SEM) of conjunctival scraping for the diagnosis of atypical cases of Acanthamoeba in culture-negative keratoconjunctivitis
    • Authors: M. Troisi, S. Del Prete, S. Troisi, D. Marasco, C. Costagliola
    • Year: 2024
    • Citations: 2
  • Compatibility of a New Ocular Surface Dye with Disposable and Bi-Weekly Soft Contact Lenses: An Experimental Study
    • Authors: M. Troisi, C. Caruso, L. D’Andrea, M. Rinaldi, R. Piscopo, S. Troisi, …
    • Year: 2024
    • Citations: 2
  • Corneal collagen cross-linking in patients with keratoconus from the Dresden protocol to customized solutions: theoretical basis
    • Authors: C. Caruso, L. D’Andrea, M. Troisi, M. Rinaldi, R. Piscopo, S. Troisi, …
    • Year: 2024
    • Citations: 2

Awards and Presentations🏅

Dr. Troisi has delivered over 30 presentations at esteemed conferences:

  • “SEM Insights into Ocular Surface and Dry Eye Management” – Finalist, Clinical Case Competition, European Dry Eye Society, 2024.
  • “Pathological Alterations of Microvilli Structure” – Winner of the EVER Scientific Photography Competition, 2024.
  • “The Role of Scanning Electron Microscopy in Acanthamoeba Diagnosis” – ESCRS, 2024.

Conclusion 🌍

Dr. Mario Troisi’s dedication to ophthalmology is evident in his clinical expertise, research contributions, and academic achievements. His innovative approach to ocular surface diseases and commitment to advancing medical knowledge position him as a rising leader in the field.